Clinical Trials Browser

Has results × STA 9090 × Breast × Clear all

NCT01560416 2026-03-03

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

Phase 2 Completed

50 enrolled 14 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01273896 2015-11-20

Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer

Phase 2 Completed

22 enrolled 6 charts

Breast Neoplasms